Annette Mattsson
General Counsel bei CAMURUS AB
Vermögen: 142 578 $ am 31.03.2024
Profil
Annette Mattsson is currently working as Vice President-Regulatory Affairs at Camurus AB since 2019.
Prior to this, she worked as Director-European RA at AstraZeneca AB.
Ms. Mattsson completed her undergraduate degree from the University of Uppsala and the University of Lund.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CAMURUS AB
0,01% | 15.12.2023 | 3 004 ( 0,01% ) | 142 578 $ | 31.03.2024 |
Aktive Positionen von Annette Mattsson
| Unternehmen | Position | Beginn |
|---|---|---|
| CAMURUS AB | General Counsel | 01.01.2019 |
Ehemalige bekannte Positionen von Annette Mattsson
| Unternehmen | Position | Ende |
|---|---|---|
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - |
Ausbildung von Annette Mattsson
| University of Uppsala | Undergraduate Degree |
| University of Lund | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CAMURUS AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
